Hippocampus DBS in Treatment-resistant Schizophrenia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The goal of this clinical trial is to assess the efficacy and safety of hippocampus-targeted deep brain stimulation (DBS) in treatment-resistant schizophrenia. The main question it aims to answer are: * whether patients with treatment-resistant schizophrenia can benefit from hippocampus-targeted DBS; * what is the neural and electrophysiological mechanism underlying the treatment effect of hippocampus-targeted DBS.
Epistemonikos ID: c6d2ddd49a30da9822984b5f790049a9ac8296ef
First added on: Feb 19, 2024